ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

BCDA BioCardia Inc

0.3803
0.0103 (2.78%)
2024年5月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
BioCardia Inc BCDA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0103 2.78% 0.3803 09:00:00
始値 安値 高値 終値 前日終値
0.37 0.37 0.40 0.3871 0.37
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2522:00GLOBEBioCardia Completes Enrollment of CardiAMP Cell Therapy for..
2024/3/2805:00GLOBEBioCardia Reports Fourth Quarter and Full Year 2023 Business..
2024/3/2020:00GLOBEBioCardia to Host 2023 Financial Results and Corporate..
2024/3/1320:00GLOBEBioCardia and StemCardia Announce Biotherapeutic Delivery..
2024/3/1220:00GLOBEBioCardia Announces CMS Approval of Coverage for CardiAMP..
2024/3/0422:00EDGAR2Form 8-K - Current report
2024/3/0422:00GLOBEBioCardia Reports Positive Interim Results from Phase III..
2024/2/2806:53EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/1521:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1507:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:17EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/0923:58EDGAR2Form 8-K - Current report
2024/2/0821:03EDGAR2Form 8-K - Current report
2024/2/0821:00GLOBEBioCardia Announces Activation of CardiAMP Heart Failure II..
2024/2/0706:28EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/2/0304:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3121:00EDGAR2Form 8-K - Current report
2024/1/3121:00GLOBEBioCardia Announces Two Scientific Abstracts Have Been..
2024/1/0321:00EDGAR2Form 8-K - Current report
2024/1/0321:00GLOBEBioCardia Biotherapeutic Delivery and Morph Access..
2023/12/1921:00EDGAR2Form 8-K - Current report
2023/12/1921:00GLOBEBioCardia Doses First Patient in CardiALLO Phase I/II..
2023/12/1821:16GLOBEBioCardia Announces Expected CardiAMP Heart Failure Japan..
2023/12/1821:00EDGAR2Form 8-K - Current report
2023/12/0620:05EDGAR2Form 8-K - Current report
2023/12/0620:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/0614:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/12/0606:11EDGAR2Form 8-K/A - Current report: [Amend]
2023/12/0606:05EDGAR2Form 8-K - Current report
2023/11/2921:00EDGAR2Form 8-K - Current report
2023/11/2921:00GLOBEBioCardia Shares Update from Japan PMDA Consultation on..
2023/11/1807:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/1707:15EDGAR2Form 8-K - Current report
2023/11/1702:56GLOBEBioCardia Announces $1.3 Million Registered Direct Offering..
2023/11/1421:15GLOBEBioCardia Announces FDA Approval of CardiAMP Heart Failure..
2023/11/0906:11GLOBEBioCardia Reports Third Quarter 2023 Business Highlights and..
2023/11/0906:08EDGAR2Form 8-K - Current report
2023/11/0906:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0206:04GLOBEBioCardia to Host Q3 2023 Corporate Update and Financial..
2023/10/2022:26EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/10/2006:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2006:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2006:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2006:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2006:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2006:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/2006:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/1905:30EDGAR2Form 8-K - Current report
2023/10/1119:04EDGAR2Form 8-K - Current report
2023/10/1119:00GLOBEBioCardia Announces Completion of Enrollment in Phase III..

最近閲覧した銘柄

Delayed Upgrade Clock